Immunogenicity and safety of measles-mumps-rubella vaccine at two different potency levels administered to healthy children aged 12-15 months: A phase III, randomized, non-inferiority trial The MMR-161 Study Group

Autor: Ahonen, A, Berry, A, Chatterjee, A, Clifford, R, Perez, C, Diez-Domingo, J, Haney, B, Harrison, C, Kerdpanich, A, Lee, J, Leonardi, M, Martinon-Torres, F, Miranda, M, Porcuna, X, Phongsamart, W, Huda, E, Toh, T, Twiggs, J, Arminana, A, Varman, M, Zissman, E, Caplanusi, A, Carryn, S, Henry, O, Povey, M, MMR-161 Study Grp

Publikováno v: Vaccine
r-FISABIO. Repositorio Institucional de Producción Científica
instname
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)

Background: The potency of live viral vaccines decreases over time. We compared the immunogenicity and safety of GSK measles-mumps-rubella vaccine (MMR-RIT) formulations at two different potencies with that of the commercially-available MMR II formul

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::05080359e032463431f3db7b8b1c1c83
https://fundanet.fisabio.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=5360

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Analysis of the cell wall of five strains of Myocbacterium tuberculosis BCG and of an attenuated human strain, W 115

Autor: Phiet, P H, Wietzerbin, J, Zissman, E, Petit, J F, Lederer, E

Publikováno v: Infection and Immunity; March 1976, Vol. 13 Issue: 3 p677-681, 5p

Improved Hospital Computer Diet Order Entry System and New Nursing Diet Dashboard Interface with Room Service System

Autor: Samour, P.Q., Zissman, E., Folcarelli, P., Shoaie, C., Demild, C., Sulmonte, K.

Publikováno v: In Journal of the American Dietetic Association 2006 106(8) Supplement:A18-A18

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.